Adolfo René Méndez‐Cruz

Dr. Adolfo René Méndez‐Cruz

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
MMMiguel Murguía-Romero
Miguel Murguía-Romero
JJJ. Rafael Jiménez-Flores
J. Rafael Jiménez-Flores
SSSantiago C. Sigrist-Flores
Santiago C. Sigrist-Flores
MEMiguel A. Espinoza-Camacho
Miguel A. Espinoza-Camacho
MJMayra Jiménez-Morales
Mayra Jiménez-Morales
GRGerald M. Reaven
Gerald M. Reaven
Studies in mature adults suggest that the plasma concentration ratio of triglyceride (TG)/HDL-cholesterol (HDL-C) provides a simple way to identify apparently healthy individuals who are insulin resistant (IR) and at increased cardiometabolic risk. This study extends these observations by examining the clinical utility of the TG/HDL-C ratio and the metabolic syndrome (MetS) in 2,244 healthy college students (17–24 years old) of Mexican Mestizo ancestry. The TG/HDL-C ratio separating the 25% with the highest value was used to identify IR and increased cardiometabolic risk. Cardiometabolic risk factors were more adverse in men and women whose TG/HDL-C ratios exceeded 3.5 and 2.5, respectively, and approximately one third were identified as being IR. The MetS identified fewer individuals as being IR, but their risk profile was accentuated. In conclusion, both a higher TG/HDL-C ratio and a diagnosis of the MetS identify young IR individuals with an increased cardiometabolic risk profile. The TG/HDL-C ratio identified a somewhat greater number of “high risk” subjects, whereas the MetS found a group whose risk profile was somewhat magnified. These findings suggest that the TG/HDL-C ratio may serve as a simple and clinically useful approach to identify apparently healthy, young individuals who are IR and at increased cardiometabolic risk.

20 December 2011 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
José Bustos-ArriagaJosé Bustos-Arriaga
José Bustos-Arriaga
JGJazmín García-Machorro
Jazmín García-Machorro
Moisés León-JuárezMoisés León-Juárez
Moisés León-Juárez
JGJulio García-Cordero
Julio García-Cordero
LSLeopoldo Santos-Argumedo
Leopoldo Santos-Argumedo
LCLeticia Cedillo-Barron
Leticia Cedillo-Barron
When mosquitoes infected with DENV are feeding, the proboscis must traverse the epidermis several times (“probing”) before reaching a blood vessel in the dermis. During this process, the salivary glands release the virus, which is likely to interact first with cells of the various epidermal and dermal layers, cells which could be physiologically relevant to DENV infection and replication in humans. However, important questions are whether more abundant non-hematopoietic cells such as fibroblasts become infected, and whether they play any role in antiviral innate immunity in the very early stages of infection, or even if they might be used by DENV as primary replication cells. Fibroblasts freshly released from healthy skin and infected 12 hours after their isolation show a positive signal for DENV. In addition, when primary skin fibroblast cultures were established and subsequently infected, we showed DENV-2 antigen-positive intracellular signal at 24 hours and 48 hours post-infection. Moreover, the fibroblasts showed productive infection in a conventional plaque assay. The skin fibroblasts infected with DENV-2 underwent potent signaling through both TLR3 and RIG- 1, but not Mda5, triggering up-regulation of IFNβ, TNFα, defensin 5 (HB5) and β defensin 2 (HβD2). In addition, DENV infected fibroblasts showed increased nuclear translocation of interferon (IFN) regulatory factor 3 (IRF3), but not interferon regulatory factor 7 (IRF7), when compared with mock-infected fibroblasts. In this work, we demonstrated the high susceptibility to DENV infection by primary fibroblasts from normal human skin, both in situ and in vitro. Our results suggest that these cells may contribute to the pro-inflammatory and anti-viral microenvironment in the early stages of interaction with DENV-2. Furthermore, the data suggest that fibroblast may also be used as a primary site of DENV replication and provide viral particles that may contribute to subsequent viral dissemination. In this work, we demonstrate that that both human whole skin and freshly isolated skin fibroblasts are productively infected with Dengue virus (DENV). In addition, primary skin fibroblast cultures were established and subsequently infected with DENV-2; we showed in these cells the presence of the viral antigen NS3, and we found productive viral infection by a conventional plaque assay. Of note, the infectivity rate was almost the same in all the primary cultures analyzed from different donors. The skin fibroblasts infected with DENV-2 underwent signaling through both TLR3 and RIG-1, but not Mda5, triggering up-regulation of IFNβ, TNFα, defensin 5 (HB5) and β defensin 2 (HβD2). In addition, DENV infected fibroblasts showed increased nuclear translocation of interferon (IFN) regulatory factor 3 (IRF3), but not interferon regulatory factor 7 IRF7, when compared with mock-infected fibroblasts. Our data suggest that fibroblasts might even participate producing mediators involved in innate immunity that activate and contribute to the orchestration of the local innate responses. This work is the first evaluating primary skin fibroblast cultures obtained from different humans, assessing both their susceptibility to DENV infection as well as their ability to produce molecules crucial for innate immunity.

29 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
NRNelly Rivera-Yañez
Nelly Rivera-Yañez
CRClaudia Rebeca Rivera
Claudia Rebeca Rivera
GPGlustein Pozo‐Molina
Glustein Pozo‐Molina
CMClaudia Fabiola Mendez-Catala
Claudia Fabiola Mendez-Catala
AMAdolfo René Méndez‐Cruz
Adolfo René Méndez‐Cruz
ONOscar Nieto-Yañez
Oscar Nieto-Yañez
The use of alternative medicine products has increased tremendously in recent decades and it is estimated that approximately 80% of patients globally depend on them for some part of their primary health care. Propolis is a beekeeping product widely used in alternative medicine. It is a natural resinous product that bees collect from various plants and mix with beeswax and salivary enzymes and comprises a complex mixture of compounds. Various biomedical properties of propolis have been studied and reported in infectious and non-infectious diseases. However, the pharmacological activity and chemical composition of propolis is highly variable depending on its geographical origin, so it is important to describe and study the biomedical properties of propolis from different geographic regions. A number of chronic diseases, such as diabetes, obesity, and cancer, are the leading causes of global mortality, generating significant economic losses in many countries. In this review, we focus on compiling relevant information about propolis research related to diabetes, obesity, and cancer. The study of propolis could generate both new and accessible alternatives for the treatment of various diseases and will help to effectively evaluate the safety of its use.

29 November 2005 in Immunology
Verified
Journal Article
Closed access
PDF file
RJRafael Jimenez‐Flores
Rafael Jimenez‐Flores
AMAdolfo René Méndez‐Cruz
Adolfo René Méndez‐Cruz
JOJorge Ojeda‐Ortiz
Jorge Ojeda‐Ortiz
RMRebeca Muñoz‐Molina
Rebeca Muñoz‐Molina
OBOscar Balderas‐Carrillo
Oscar Balderas‐Carrillo
LFLeopoldo Flores‐Romo
Leopoldo Flores‐Romo

Verified
Journal Article
Open access
PDF file
AMAdriana Morales-Martínez
Adriana Morales-Martínez
PMPaola A. Martínez-Gómez
Paola A. Martínez-Gómez
DMDaniel Martinez-Fong
Daniel Martinez-Fong
MRMarcos Mauricio Villegas Rojas
Marcos Mauricio Villegas Rojas
FPFrancisca Perez-Severiano
Francisca Perez-Severiano
Luis O. Soto-RojasLuis O. Soto-Rojas
Luis O. Soto-Rojas
The α-synucleinopathies constitute a subset of neurodegenerative disorders, of which Parkinson’s disease (PD) is the most common worldwide, characterized by the accumulation of misfolded α-synuclein in the cytoplasm of neurons, which spreads in a prion-like manner to anatomically interconnected brain areas. However, it is not clear how α-synucleinopathy triggers neurodegeneration. We recently developed a rat model through a single intranigral administration of the neurotoxic β-sitosterol β-D-glucoside (BSSG), which produces α-synucleinopathy. In this model, we aimed to evaluate the temporal pattern of levels in oxidative and nitrosative stress and mitochondrial complex I (CI) dysfunction and how these biochemical parameters are associated with neurodegeneration in different brain areas with α-synucleinopathy (Substantia nigra pars compacta, the striatum, in the hippocampus and the olfactory bulb, where α-syn aggregation spreads). Interestingly, an increase in oxidative stress and mitochondrial CI dysfunction accompanied neurodegeneration in those brain regions. Furthermore, in silico analysis suggests a high-affinity binding site for BSSG with peroxisome proliferator-activated receptors (PPAR) alpha (PPAR-α) and gamma (PPAR-γ). These findings will contribute to elucidating the pathophysiological mechanisms associated with α-synucleinopathies and lead to the identification of new early biomarkers and therapeutic targets.

12 May 2021 in Biology
Verified
Journal Article
Open access
PDF file
NRNelly Rivera-Yañez
Nelly Rivera-Yañez
CRClaudia Rebeca Rivera
Claudia Rebeca Rivera
GPGlustein Pozo‐Molina
Glustein Pozo‐Molina
CMClaudia Fabiola Mendez-Catala
Claudia Fabiola Mendez-Catala
JRJulia Reyes-Reali
Julia Reyes-Reali
ONOscar Nieto-Yañez
Oscar Nieto-Yañez
Infectious diseases are a significant problem affecting the public health and economic stability of societies all over the world. Treatment is available for most of these diseases; however, many pathogens have developed resistance to drugs, necessitating the development of new therapies with chemical agents, which can have serious side effects and high toxicity. In addition, the severity and aggressiveness of emerging and re-emerging diseases, such as pandemics caused by viral agents, have led to the priority of investigating new therapies to complement the treatment of different infectious diseases. Alternative and complementary medicine is widely used throughout the world due to its low cost and easy access and has been shown to provide a wide repertoire of options for the treatment of various conditions. In this work, we address the relevance of the effects of propolis on the causal pathogens of the main infectious diseases with medical relevance; the existing compiled information shows that propolis has effects on Gram-positive and Gram-negative bacteria, fungi, protozoan parasites and helminths, and viruses; however, challenges remain, such as the assessment of their effects in clinical studies for adequate and safe use.